Interaction between smoking, and the glycoprotein IIIa P1A2 polymorphism in non-ST-segment elevation acute coronary syndromes

被引：0

作者：

Barakat, K

Kennon, S

Hitman, GA

Aganna, E

Price, C

Mills, PG

Ranjadayalan, K

North, B

Clarke, GH

Timmis, AD

机构：

[1] London Chest Hosp, Dept Cardiol, London E2 9JX, England

[2] Univ London Queen Mary Coll, SBRLSM, London, England

[3] Barts & London NHS Trust, Dept Clin Biochem, London, England

[4] Newham Healthcare Trust, Dept Cardiol, London, England

[5] Univ London Queen Mary Coll, SBRLSMD, Dept Med Psychol, London, England

来源：

EUROPEAN HEART JOURNAL | 2001年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：150 / 150

页数：1

共 50 条

[31] Effects of platelet glycoprotein IIb/IIIa receptor blockers in non-ST-segment elevation acute coronary syndromes: benefit and harm in different age subgroups
Diaz, A. V. Hernandez
Westerhout, C. M.
Steyerberg, E. W.
Ioannidis, J. P. A.
Bueno, H.
Califf, R. M.
Simoons, M. L.
Boersma, E.
EUROPEAN HEART JOURNAL, 2006, 27 : 759 - 759
[32] Early use of glycoprotein IIb/IIIa inhibitors in the ED treatment of non-ST-segment elevation acute coronary syndromes: A local quality improvement initiative
Fesmire, FM
Peterson, ED
Roe, MT
Wojcik, JF
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2003, 21 (04) : 304 - 308
[33] Trials of glycoprotein IIb-IIIa inhibitors in non-ST-segment elevation acute coronary syndromes: Applicability to the practice of medicine in the United States - Introduction
Parmley, WW
CLINICAL CARDIOLOGY, 1999, 22 (10) : 1 - 1
[34] Cost-effectiveness of bivalirudin versus heparin plus glycoprotein IIb/IIIa inhibitor in the treatment of non-ST-segment elevation acute coronary syndromes
Schwenkglenks, Matthias
Brazier, John E.
Szucs, Thomas D.
Fox, Keith A. A.
VALUE IN HEALTH, 2011, 14 (01) : 24 - 33
[35] Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology: reply
Bassand, Jean-Pierre
Hamm, Christian
EUROPEAN HEART JOURNAL, 2008, 29 (02) : 278 - 279
[36] Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes
Roffi, M
Topol, EJ
EUROPEAN HEART JOURNAL, 2004, 25 (03) : 190 - 198
[37] Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes
Riezebos, R. K.
Ronner, E.
ter Bals, E.
Slagboom, T.
Smits, P. C.
ten Berg, J. M.
Kiemeneij, F.
Amoroso, G.
Patterson, M. S.
Suttorp, M. J.
Tijssen, J. G. P.
Laarman, G. J.
HEART, 2009, 95 (10) : 807 - 812
[38] Non-ST-segment elevation acute coronary syndromes: Management strategies for optimal outcomes
Housholder-Hughes, SD
CRITICAL CARE NURSE, 2006, : 8 - +
[39] Glycoprotein IIb/IIIa Receptor Therapy in Percutaneous Coronary Intervention and Non-ST-Segment Elevation Acute Coronary SyndromesEstimating the Economic Implications
William B. Hillegass
Anne R. Newman
Dominic L. Raco
PharmacoEconomics, 2001, 19 : 41 - 55
[40] Insurance coverage and care of patients with Non-ST-Segment elevation acute coronary syndromes
Calvin, James E.
Roe, Matthew T.
Peterson, Eric D.
ANNALS OF INTERNAL MEDICINE, 2007, 147 (03) : 212 - 212

← 1 2 3 4 5 →